Xenon Pharmaceuticals IncNASDAQ:XENE
- LAST PRICE38.6100
- TODAY'S CHANGE (%)0.2400 (0.6255%)
- Bid / Lots35.0000/ 1
- Ask / Lots61.3800/ 1
- Open / Previous Close38.7700 / 38.3700
- Day Range
- 52 Week Range
- Volume331,221
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | XENE |
|---|---|---|
| 09:32 ET | 795 | 38.77 |
| 09:34 ET | 816 | 38.1494 |
| 09:39 ET | 2032 | 39 |
| 09:41 ET | 2062 | 39.18 |
| 09:48 ET | 200 | 38.89 |
| 09:50 ET | 100 | 38.96 |
| 09:54 ET | 200 | 38.81 |
| 09:56 ET | 322 | 38.755 |
| 09:57 ET | 6604 | 38.65 |
| 09:59 ET | 1770 | 38.625 |
| 10:01 ET | 2536 | 38.835 |
| 10:03 ET | 140 | 38.815 |
| 10:06 ET | 500 | 38.73 |
| 10:12 ET | 200 | 38.655 |
| 10:17 ET | 511 | 38.71 |
| 10:21 ET | 200 | 38.715 |
| 10:24 ET | 500 | 38.85 |
| 10:26 ET | 200 | 38.735 |
| 10:30 ET | 2519 | 38.685 |
| 10:32 ET | 666 | 38.605 |
| 10:35 ET | 900 | 38.675 |
| 10:37 ET | 1100 | 38.705 |
| 10:39 ET | 300 | 38.75 |
| 10:42 ET | 810 | 38.73 |
| 10:46 ET | 300 | 38.76 |
| 10:48 ET | 100 | 38.75 |
| 10:51 ET | 100 | 38.695 |
| 10:53 ET | 100 | 38.71 |
| 10:55 ET | 900 | 38.665 |
| 10:57 ET | 230 | 38.665 |
| 11:00 ET | 100 | 38.7 |
| 11:02 ET | 1024 | 38.68 |
| 11:04 ET | 1195 | 38.76 |
| 11:06 ET | 302 | 38.77 |
| 11:08 ET | 200 | 38.77 |
| 11:11 ET | 200 | 38.82 |
| 11:13 ET | 100 | 38.82 |
| 11:15 ET | 900 | 38.85 |
| 11:22 ET | 200 | 38.81 |
| 11:27 ET | 100 | 38.86 |
| 11:29 ET | 807 | 38.885 |
| 11:31 ET | 100 | 38.94 |
| 11:33 ET | 2298 | 38.78 |
| 11:36 ET | 136 | 38.73 |
| 11:38 ET | 100 | 38.76 |
| 11:40 ET | 700 | 38.75 |
| 11:44 ET | 200 | 38.765 |
| 11:45 ET | 100 | 38.82 |
| 11:47 ET | 100 | 38.77 |
| 11:51 ET | 100 | 38.82 |
| 11:58 ET | 200 | 38.71 |
| 12:00 ET | 2228 | 38.68 |
| 12:02 ET | 340 | 38.67 |
| 12:05 ET | 500 | 38.595 |
| 12:07 ET | 105 | 38.555 |
| 12:09 ET | 200 | 38.555 |
| 12:12 ET | 300 | 38.555 |
| 12:14 ET | 160 | 38.555 |
| 12:20 ET | 500 | 38.555 |
| 12:21 ET | 930 | 38.4 |
| 12:23 ET | 100 | 38.39 |
| 12:27 ET | 200 | 38.45 |
| 12:34 ET | 1100 | 38.34 |
| 12:36 ET | 100 | 38.285 |
| 12:38 ET | 1516 | 38.36 |
| 12:48 ET | 200 | 38.27 |
| 12:50 ET | 507 | 38.265 |
| 12:52 ET | 300 | 38.2582 |
| 12:56 ET | 100 | 38.255 |
| 12:57 ET | 100 | 38.22 |
| 12:59 ET | 1742 | 38.34 |
| 01:03 ET | 200 | 38.34 |
| 01:08 ET | 100 | 38.34 |
| 01:10 ET | 200 | 38.39 |
| 01:12 ET | 773 | 38.37 |
| 01:14 ET | 200 | 38.43 |
| 01:15 ET | 365 | 38.395 |
| 01:17 ET | 200 | 38.395 |
| 01:19 ET | 700 | 38.51 |
| 01:21 ET | 100 | 38.51 |
| 01:24 ET | 500 | 38.465 |
| 01:26 ET | 200 | 38.5 |
| 01:28 ET | 556 | 38.47 |
| 01:30 ET | 110 | 38.515 |
| 01:32 ET | 100 | 38.57 |
| 01:33 ET | 2086 | 38.5 |
| 01:35 ET | 800 | 38.42 |
| 01:37 ET | 125 | 38.44 |
| 01:42 ET | 2136 | 38.5 |
| 01:44 ET | 200 | 38.44 |
| 01:46 ET | 940 | 38.43 |
| 01:50 ET | 205 | 38.45 |
| 01:51 ET | 186 | 38.405 |
| 01:53 ET | 100 | 38.405 |
| 01:55 ET | 600 | 38.39 |
| 02:00 ET | 100 | 38.37 |
| 02:02 ET | 100 | 38.39 |
| 02:04 ET | 500 | 38.4 |
| 02:06 ET | 511 | 38.395 |
| 02:09 ET | 212 | 38.45 |
| 02:11 ET | 309 | 38.51 |
| 02:13 ET | 100 | 38.55 |
| 02:18 ET | 2300 | 38.575 |
| 02:20 ET | 100 | 38.54 |
| 02:22 ET | 1850 | 38.63 |
| 02:26 ET | 1133 | 38.655 |
| 02:27 ET | 600 | 38.7 |
| 02:31 ET | 200 | 38.67 |
| 02:33 ET | 100 | 38.67 |
| 02:38 ET | 2298 | 38.63 |
| 02:42 ET | 100 | 38.59 |
| 02:44 ET | 100 | 38.58 |
| 02:45 ET | 402 | 38.6 |
| 02:47 ET | 2932 | 38.555 |
| 02:51 ET | 2296 | 38.56 |
| 02:56 ET | 410 | 38.58 |
| 02:58 ET | 600 | 38.58 |
| 03:00 ET | 600 | 38.56 |
| 03:03 ET | 1502 | 38.55 |
| 03:07 ET | 1300 | 38.55 |
| 03:12 ET | 705 | 38.58 |
| 03:14 ET | 548 | 38.58 |
| 03:16 ET | 1167 | 38.58 |
| 03:18 ET | 904 | 38.63 |
| 03:20 ET | 200 | 38.66 |
| 03:21 ET | 900 | 38.63 |
| 03:23 ET | 900 | 38.58 |
| 03:25 ET | 500 | 38.59 |
| 03:27 ET | 100 | 38.58 |
| 03:30 ET | 200 | 38.585 |
| 03:32 ET | 906 | 38.635 |
| 03:34 ET | 406 | 38.66 |
| 03:36 ET | 503 | 38.66 |
| 03:38 ET | 100 | 38.66 |
| 03:39 ET | 200 | 38.69 |
| 03:43 ET | 1963 | 38.7 |
| 03:45 ET | 1248 | 38.71 |
| 03:50 ET | 100 | 38.72 |
| 03:52 ET | 1860 | 38.57 |
| 03:54 ET | 1910 | 38.615 |
| 03:56 ET | 12391 | 38.61 |
| 03:57 ET | 8096 | 38.61 |
| 03:59 ET | 34060 | 38.61 |
Today
May 10, 2024
DJ Xenon Pharmaceuticals Is Maintained at Buy by Needham, from 6:12PM ET on Friday May 10, 2024 by Dow Jones
6:12PM ET on Friday May 10, 2024 by Dow JonesDJ Xenon Pharmaceuticals Is Maintained at Buy by Citigroup, from 5:48PM ET on Friday May 10, 2024 by Dow Jones
5:48PM ET on Friday May 10, 2024 by Dow JonesDJ Xenon Pharmaceuticals Is Maintained at Outperform by Wedbush, from 9:30AM ET on Friday May 10, 2024 by Dow Jones
9:30AM ET on Friday May 10, 2024 by Dow Jones
May 9, 2024
*DJ Xenon Pharmaceuticals 1Q Loss/Shr 62c >XENE, from 4:01PM ET on Thursday May 09, 2024 by Dow Jones
4:01PM ET on Thursday May 09, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Xenon Pharmaceuticals Inc | 2.9B | -14.2x | --- |
Apogee Therapeutics Inc | 2.8B | -23.4x | --- |
Iovance Biotherapeutics Inc | 2.8B | -5.3x | --- |
Dyne Therapeutics Inc | 3.0B | -7.6x | --- |
IDEAYA Biosciences Inc | 2.9B | -18.8x | --- |
Vitaspring Biomedical Co. Ltd | 3.1B | 3,311.3x | --- |
Company Information
Xenon Pharmaceuticals Inc. is a Canada-based clinical-stage biopharmaceutical company focused on developing therapeutics to improve the lives of patients with neurological disorders, with a focus on epilepsy. The Company’s product pipeline includes XEN1101 (Focal Onset Seizures), XEN1101 (Primary Generalized Tonic-Clonic Seizures), XEN1101 (Major Depressive Disorder) and NBI-921352 (NEUROCRINE). It is developing XEN1101, a differentiated Kv7 potassium channel opener, for the treatment of epilepsy, MDD and potentially other neurological disorders. Its XEN1101 Phase III epilepsy program includes two identical Phase III clinical trials, called X-TOLE2 and X-TOLE3, that are designed closely after the Phase IIb X-TOLE clinical trial. Its Phase III X-ACKT clinical trial is intended to support potential regulatory submissions in an additional epilepsy indication of primary generalized tonic-clonic seizures (PGTCS).
Contact Information
- Headquarters
- 3650 Gilmore WayVANCOUVER, BC, Canada V5G 4W8
- Phone
- 604-484-3300
- Fax
- 604-484-3450
Executives
- Chairman of the Board
- Simon Pimstone
- President, Chief Executive Officer, Director
- Ian Mortimer
- Chief Financial Officer
- Sherry Aulin
- Executive Vice President - Drug Discovery
- James Empfield
- Executive Vice President - Strategy and Innovation
- Robin Sherrington
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.9B |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 75.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.23 |
EPS | $-2.71 |
Book Value | $12.31 |
P/E Ratio | -14.2x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
